Oncology

Now that bispecifics have cleared the clinical bar, explore how reimbursement risk, care-setting economics, and payer confidence will determine which therapies scale.

Explore the macro trends reshaping oncology, from the pace of FDA approvals and liquid biopsy to AI, and what each means for pharma brand teams.

Read how ASCO 2025 spotlighted breakthrough innovations and their impact on the cancer care community—and what it means for teams shaping the future of oncology.

Understand how life sciences leaders can ease the cognitive and emotional load oncologists face amid data overload, burnout, and nonstop decision-making.

It’s time to consider how the hidden burden of time toxicity shapes cancer care. Explore why addressing it can unlock better outcomes, equity, and a positive brand experience.

Oncology engagement is evolving. Learn how AI, real-world data, and digital behaviors are reshaping how we connect with time-pressed HCPs in a fast-moving field.

See how AI, telemedicine, and digital screening are transforming cancer care—and why true equity demands broadband access, trust, and systemic investment.

Focus groups can’t keep pace with the urgency of oncology. AI-driven simulations are changing the game—delivering insights on how oncologists respond to efficacy, safety, and compe...

Oncology is looking more and more like a rare disease in its treatment, with a shift towards hyper-personalized care and deploying digital tools that empower patients, advocates, a...

In this interview, Klick Health’s Jasmine Singh sits down with Dr. Rahul Banerjee from Fred Hutchinson Cancer Institute to discuss the concept of “Time Toxicity” in cancer care. Th...

Jasmine Singh, EVP Medical Strategy, Klick Health, sits down with Dr. Scott Kopetz from MD Anderson to talk about minimal residual disease and why cancer that doesn’t show up on a ...

Jasmine Singh, EVP, Medical Strategy – Growth and Innovation, Klick Health, sits down with Dr. Sanjay Juneja, practicing hematologist and oncologist, to talk about where AI is alre...